Literature DB >> 19646728

TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS.

Hyeon-Sook Suh1, Meng-Liang Zhao, Namjong Choi, Thomas J Belbin, Celia F Brosnan, Sunhee C Lee.   

Abstract

In the CNS, microglia are the primary targets of HIV infection. In this study, we investigated the effect of activation of the innate antiviral receptors TLR3 and TLR4 on HIV infection of primary human microglia, as well as microglial cell signaling and gene expression. Ligands for both TLR3 and TLR4 potently inhibited HIV replication in microglia through a pathway requiring IRF3. Surprisingly, a remarkably similar pattern of cell signaling and gene expression was observed in TLR3- and TLR4-activated microglia, suggesting a relatively minor role for MyD88 following TLR4 activation in these cells. HIV did not activate IRF3 but rather decreased IRF3 protein, indicating that HIV does not activate TLR3 or RIG-like helicases in microglia. Taken together, these results indicate that activation of TLR3 or TLR4 will elicit antiviral immunity, in addition to inducing proinflammatory responses. We suggest that a balanced expression between inflammatory and innate immune genes might be achieved by IRF3 over-expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646728      PMCID: PMC2752833          DOI: 10.1016/j.virol.2009.07.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  91 in total

1.  Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia.

Authors:  L L Hua; S C Lee
Journal:  Glia       Date:  2000-03       Impact factor: 7.452

2.  Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia.

Authors:  S C Lee; W Liu; C F Brosnan; D W Dickson
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

3.  In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression.

Authors:  Clive S McKimmie; John K Fazakerley
Journal:  J Neuroimmunol       Date:  2005-09-06       Impact factor: 3.478

4.  Hitching RIG to action.

Authors:  Ganes C Sen; Saumendra N Sarkar
Journal:  Nat Immunol       Date:  2005-11       Impact factor: 25.606

Review 5.  Antiviral signaling through pattern recognition receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  J Biochem       Date:  2006-12-26       Impact factor: 3.387

6.  Preferential expression and function of Toll-like receptor 3 in human astrocytes.

Authors:  Cinthia Farina; Markus Krumbholz; Thomas Giese; Gunther Hartmann; Francesca Aloisi; Edgar Meinl
Journal:  J Neuroimmunol       Date:  2004-11-11       Impact factor: 3.478

7.  Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components.

Authors:  N Laflamme; S Rivest
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

Review 8.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

9.  Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells.

Authors:  Qiusheng Si; Mee-Ohk Kim; Meng-Liang Zhao; Nathaniel R Landau; Harris Goldstein; Sunhee Lee
Journal:  Virology       Date:  2002-09-30       Impact factor: 3.616

10.  HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation.

Authors:  Atsushi Okumura; Tim Alce; Barbora Lubyova; Heather Ezelle; Klaus Strebel; Paula M Pitha
Journal:  Virology       Date:  2007-12-20       Impact factor: 3.616

View more
  35 in total

1.  Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*.

Authors:  Leonid Tarassishin; Olivier Loudig; Avital Bauman; Bridget Shafit-Zagardo; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2011-12       Impact factor: 7.452

Review 2.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells.

Authors:  Wilbert A Derbigny; LaTasha R Shobe; Jasmine C Kamran; Katherine S Toomey; Susan Ofner
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

4.  Protective role of interferon regulatory factor 3-mediated signaling against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Takayuki Fuse; Takehiro Nakagaki; Naohiro Yamaguchi; Katsuya Satoh; Kenya Honda; Noriyuki Nishida
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

5.  Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.

Authors:  Khutso M Mothapo; J Ten Oever; P Koopmans; F F Stelma; S Burm; J Bajramovic; M M Verbeek; M G Olde Rikkert; M G Netea; G Koopman; A J van der Ven
Journal:  J Neurovirol       Date:  2016-11-23       Impact factor: 2.643

Review 6.  Anti-viral and anti-inflammatory mechanisms of the innate immune transcription factor interferon regulatory factor 3: relevance to human CNS diseases.

Authors:  Leonid Tarassishin; Avital Bauman; Hyeon-Sook Suh; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-10       Impact factor: 4.147

7.  The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1.

Authors:  Daniela Krause; Hyeon-Sook Suh; Leonid Tarassishin; Qiao Ling Cui; Bryce A Durafourt; Namjong Choi; Avital Bauman; Melissa Cosenza-Nashat; Jack P Antel; Meng-Liang Zhao; Sunhee C Lee
Journal:  Am J Pathol       Date:  2011-09       Impact factor: 4.307

8.  Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders.

Authors:  Hyeon-Sook Suh; Melissa Cosenza-Nashat; Namjong Choi; Meng-Liang Zhao; Jiu-feng Li; Jeffrey W Pollard; Randy L Jirtle; Harris Goldstein; Sunhee C Lee
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

9.  Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging.

Authors:  Aisling A Murphy; Pamela C Rosato; Zachary M Parker; Alexey Khalenkov; David A Leib
Journal:  Virology       Date:  2013-06-16       Impact factor: 3.616

10.  Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.

Authors:  Biju Bhargavan; Shawna M Woollard; Georgette D Kanmogne
Journal:  Cell Signal       Date:  2015-11-11       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.